Photo:
worldthrombosisday.org
Sep 24, 2026, 14:22
Integrating Thrombosis Risk Into Menopause Care – World Thrombosis Day
World Thrombosis Day shared a post on LinkedIn:
“For women with inherited thrombophilias or a history of blood clots, menopause treatment requires careful consideration of thrombosis risk.
Conditions such as Factor V Leiden or prothrombin gene mutation may increase the risk of blood clots with hormone replacement therapy (HRT).
For some patients, transdermal HRT may be an appropriate option, but treatment decisions should be individualized through careful risk assessment and shared decision-making.
This World Thrombosis Day, help ensure thrombosis risk is part of the conversation when discussing menopause care.”
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?